inv-Myc-ERTAM mice treated with 4-hydroxytamoxifen to activate Myc, quickly presented papillomatosis associated with hyperkeratosis and hypergranulosis, but double transgenic inv-Myc-ERTAM/Omomyc treated in the same way did not (Figure 2). Here, MYC is linked to Hyperkeratosis.